Huang L - Search Results

1

MIP3α as an early prognostic predictor for patients with B-cell malignancies receiving CD19/CD22-redirected CAR-T cell cocktail therapy.

Jin J, Liu T, Cheng J, Meng J, Wang N, Huang L, Zhou X, Chen L, Luo H, Zhou J. Jin J, et al. Among authors: huang l. Cancer Immunol Immunother. 2023 Jul;72(7):2245-2256. doi: 10.1007/s00262-023-03418-2. Epub 2023 Mar 4. Cancer Immunol Immunother. 2023. PMID: 36869895 Free PMC article.

2

Curative effect of combined lamivudine, adefovir dipivoxil, and stem cell transplantation on decompensated hepatitis B cirrhosis.

Liu L, Yan Y, Zhou J, Huang LW, He CP, Ling K, Zhou HC, Wen QM, Wang XM. Liu L, et al. Among authors: huang lw. Genet Mol Res. 2014 Feb 21;13(4):9336-42. doi: 10.4238/2014.February.21.13. Genet Mol Res. 2014. PMID: 24634299 Free article. Clinical Trial.

3

Efficacy and safety of chimeric antigen receptor T-cell therapy targeting CD19/CD22 in refractory/relapsed transformed aggressive B-cell lymphoma.

Xu H, Lv Q, Huang L, Cao W, Wang J, Meng F, Li C, Zheng M, Chen L, Mu K, Cheng J, Zhu L, Zhou J, Zhang Y, Wang N, Cao Y. Xu H, et al. Among authors: huang l. Cytotherapy. 2023 Feb;25(2):185-191. doi: 10.1016/j.jcyt.2022.10.001. Epub 2022 Oct 22. Cytotherapy. 2023. PMID: 36283943 No abstract available.

4

Preclinical development and evaluation of nanobody-based CD70-specific CAR T cells for the treatment of acute myeloid leukemia.

Cheng J, Ge T, Zhu X, Wang J, Zeng Y, Mu W, Cai H, Dai Z, Jin J, Yang Y, Hu G, Mao X, Zhou J, Zhu L, Huang L. Cheng J, et al. Among authors: huang l. Cancer Immunol Immunother. 2023 Jul;72(7):2331-2346. doi: 10.1007/s00262-023-03422-6. Epub 2023 Mar 17. Cancer Immunol Immunother. 2023. PMID: 36932256 Free PMC article.

5

Outcomes of programmed death protein-1 inhibitors treatment of chronic active Epstein Barr virus infection: A single center retrospective analysis.

Ma Y, Zhang P, Bao Y, Luo H, Wang J, Huang L, Zheng M. Ma Y, et al. Among authors: huang l. Front Immunol. 2023 Mar 10;14:1093719. doi: 10.3389/fimmu.2023.1093719. eCollection 2023. Front Immunol. 2023. PMID: 36969150 Free PMC article.

6

Case Report: Fatal cytomegalovirus pneumonia after CAR-T cell therapy in the long-term follow-up.

Cheng J, Huang J, Cao W, Huang L, Mao X, Chen L, Zhou J, Wang N. Cheng J, et al. Among authors: huang l, huang j. Front Immunol. 2023 Oct 2;14:1226148. doi: 10.3389/fimmu.2023.1226148. eCollection 2023. Front Immunol. 2023. PMID: 37849765 Free PMC article.

7

EBV-Encoded MicroRNA-BART17-3p Targets DDX3X and Promotes EBV Infection in EBV-Associated T/Natural Killer-Cell Lymphoproliferative Diseases.

Jin J, Sun T, Zhang M, Cheng J, Gu J, Huang L, Xiao M, Zhou J, Luo H. Jin J, et al. Among authors: huang l. Open Forum Infect Dis. 2023 Oct 20;10(11):ofad516. doi: 10.1093/ofid/ofad516. eCollection 2023 Nov. Open Forum Infect Dis. 2023. PMID: 38023563 Free PMC article.

8

Case report: Differential diagnosis of highly amplified anti-CD5 CAR T cells and relapsed lymphoma cells in a patient with refractory ALK positive anaplastic large cell lymphoma.

Mu W, Zhang M, Hu G, Han Y, Mao X, Chen C, Shen K, Dai Z, Zhu X, Zhou X, Huang L, Ao Q, Xiao M. Mu W, et al. Among authors: huang l. Front Immunol. 2023 Dec 8;14:1280007. doi: 10.3389/fimmu.2023.1280007. eCollection 2023. Front Immunol. 2023. PMID: 38143760 Free PMC article.

9

Efficient 3D imaging and pathological analysis of the human lymphoma tumor microenvironment using light-sheet immunofluorescence microscopy.

Chen L, Meng J, Zhou Y, Zhao F, Ma Y, Feng W, Chen X, Jin J, Gao S, Liu J, Zhang M, Liu A, Hong Z, Tang J, Kuang D, Huang L, Zhang Y, Fei P. Chen L, et al. Among authors: huang l. Theranostics. 2024 Jan 1;14(1):406-419. doi: 10.7150/thno.86221. eCollection 2024. Theranostics. 2024. PMID: 38164148 Free PMC article.

10

Upper gastrointestinal tract immune-related adverse events: Two cases of obstructive complications occurred in immune consolidation therapy after sequential chimeric antigen receptor T cell therapy with autologous hematopoietic stem cell transplantation for refractory/relapsed diffuse large B cell lymphoma.

Zhang Q, Li C, Cao Y, Wang N, Huang L, Shang Z, Wang J, Huang L, Xu J, Xiao M, Chen L, Zhu X, Zhang Y, Xiao Y. Zhang Q, et al. Among authors: huang l. Clin Case Rep. 2024 Jan 17;12(1):e8411. doi: 10.1002/ccr3.8411. eCollection 2024 Jan. Clin Case Rep. 2024. PMID: 38235413 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34,830 results

Search Page

Filters